Abstract
To determine whether different forms of C3 degrade at different rates, we compared two strains of mice with a B10 background. The only difference was that one is C3A, while the other is OR These strains allow comparison of C3A and C3B without the added complication of differing C3 convertases. Sera from the two strains were incubated with zymosan and the degradation products were detected by immunofixation following electrophoresis in agarose. The rate of degradation of mouse C3B was more rapid than that of C3A. Differences in the rates of degradation could not be explained by differing concentrations of C3. We suggest that the genetic differences in C3 determine the decay rate following activation via the alternate pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arvilommi, H.: Capacity of complement C3 phenotypes to bind on to mononuclear cells in man. Nature 251: 740–741, 1974
Awdeh, Z. L. and Alper, C. A.: Inherited structural polymorphism of the fourth component of human complement. Proc. Natl. Acad. Sci. U.S.A. 77: 3576–3580, 1980
Bronnestam, R.: Studies of the C3 polymorphism. Relationship between C3 phenotypes and rheumatoid arthritis. Hum. Hered. 23: 206–213, 1973
Da Silva, F. P., Hoecker, G. F., Day, N. K., Vienne, K., and Rubinstein, P.: Murine complement component C3: genetic variation and linkage to H-2. Proc. Nod. Acad. Sci. U.S.A. 75: 963–965, 1978
Elmgreen, J., Sorensen, H., and Berkowicz, A.: Polymorphism of complement C3 in chronic inflammatory bowel disease. Acta Med. Scand. 215: 375–378, 1984
Gyongyossy, M. I. and Assimeh, S. N.: Isolation of the third component of mouse complement. J. Immunol. 118: 1032–1035, 1977
Jans, H. and Sorensen, H.: C3 polymorphism and circulating immune complexes in patients with multiple sclerosis. Acta Neurol. Scand. 62: 237–243, 1980
Laemmli, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Mancini, G., Carbonara, A. O., and Heremans, J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235–241, 1965
Mardinay, M. R. and Muller-Eberhard H. J.: Mouse beta-1C globulin: Production of antiserum and characterisation of the complement reaction. J. Immunol. 94: 877–882, 1965
Morgan, E. L., Weigle, W. O., and Hugh, T. E.: Anaphylotoxin-mediated regulation of the immune response. J. Exp. Med. 155: 1412–1426, 1982
Natsuume-Sakai, S., Kondo, K., and Migita, S.: Quantitative estimation of serum Ss level: Changes upon the development of autoantibodies, environment and acute inflammation in inbred mice. Jpn. J. Exp. Med. 47: 117–123, 1977
Natsuume-Sakai, S., Hayakawa, J., and Takahashi, M.: Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17. J. Immunol. 121: 491–498, 1978a
Natsuume-Sakai, S., Amano, S., Hayakawa, J.-I., and Takahashi, M.: Preparation of an alloantiserum to murine C3 and demonstration of multiple alleles. J. Immunol. 121: 2025–2029, 1978b
Natsuume-Sakai, S., Moriwaki, K., Migita, S., Sudo, K., Suzuki, K., Lu, D.-Y., Wang, C., and Takahashi, M.: Structural polymorphism of murine factor B controlled by a locus closely linked to the H-2 complex and demonstration of multiple alleles. Immunogenetics 18: 117–124, 1983
Natsuume-Sakai, S., Sudoh, K., Daidoh, T., Hayakawa, J.-L, and Takahashi, M.: Structural polymorphism of murine complement factor H controlled by a locus located between the He and the beta-2M locus on the second chromosome of the mouse. J. Immunol. 134: 2600–2606, 1985
Nonaka, M., Natsuume-Sakai, S., Kaidoh, T., Nonaka, M., and Takahashi, M.: Characterisation of allotypic determinants of murine complement C3. J. Immunol. 125: 2025–2030, 1980
Pepys, M. B., Dash, A. C., Fielder, A. H. L., and Mirjah, D. D.: Isolation and study of murine C3. Immunology 33: 491–499, 1977
Ross, G. D.: Structure and function of membrane complement receptors. Fed. Proc. 41: 3089–3093, 1982
Sorensen, H. and Dissing, J.: Association between the C3F gene and atherosclerotic vascular diseases. Hum. Hered. 25: 279–283, 1975
Williams, C. A. and Wemyss, C. T.: Changes produced in mouse plasma proteins by acute bacterial infections. J. Exp. Med. 114: 311–325, 1961
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kay, P.H., Natsuume-Sakai, S., Hayakawa, J. et al. Different allotypes of C3 degrade at different rates. Immunogenetics 22, 563–569 (1985). https://doi.org/10.1007/BF00430304
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00430304